These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25856080)

  • 21. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
    Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
    Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Natural killer cell activation contributes to hepatitis B viral control in a mouse model.
    Tong S; Liu G; Li M; Li X; Liu Q; Peng H; Li S; Ren H; Yin W
    Sci Rep; 2017 Mar; 7(1):314. PubMed ID: 28331190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the function of circulating plasmacytoid dendritic cells in the immunoactive phase of patients with chronic genotype B and C HBV infection.
    Wang K; Fan X; Fan Y; Wang B; Han L; Hou Y
    J Viral Hepat; 2007 Apr; 14(4):276-82. PubMed ID: 17381720
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro.
    Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L
    Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Feedback regulation of IFN-α/β signaling by Axl receptor tyrosine kinase modulates HBV immunity.
    Huang MT; Liu WL; Lu CW; Huang JJ; Chuang HL; Huang YT; Horng JH; Liu P; Han DS; Chiang BL; Shih C; Chen PJ; Chen DS
    Eur J Immunol; 2015 Jun; 45(6):1696-705. PubMed ID: 25820812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine.
    Zhou C; Peng G; Jin X; Tang J; Chen Z
    Clin Immunol; 2010 Nov; 137(2):190-8. PubMed ID: 20692873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic comparison reveals dynamic differences in early adaptive immune responses of acute-resolving versus chronic HBV replication.
    Wang Q; Liu Y; Luo J; Yang S; Wang L; Lu Y; Feng X; Yang X; Sutter K; Dittmer U; Lu M; Zheng X; Yang D; Liu J
    J Med Virol; 2023 Mar; 95(3):e28670. PubMed ID: 36916726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
    Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
    Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of hepatitis B virus-induced systemic immune tolerance by intrinsic innate immune stimulation.
    Han Q; Lan P; Zhang J; Zhang C; Tian Z
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():132-7. PubMed ID: 23855309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.
    Tian J; Ma J; Wang S; Yan J; Chen J; Tong J; Wu C; Liu Y; Ma B; Mao C; Jiao Z; Shao Q; Lu L; Xu H
    Cell Immunol; 2011; 270(2):183-7. PubMed ID: 21636079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CpG oligodeoxynucleotide inhibits HBV replication in a hydrodynamic injection murine model.
    Hu W; Huang H; Zhang TY; Mao YY; Wang XJ; Wang SQ
    Antivir Ther; 2015; 20(3):289-95. PubMed ID: 25279542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cells expressing a chimeric antigen receptor that binds hepatitis B virus envelope proteins control virus replication in mice.
    Krebs K; Böttinger N; Huang LR; Chmielewski M; Arzberger S; Gasteiger G; Jäger C; Schmitt E; Bohne F; Aichler M; Uckert W; Abken H; Heikenwalder M; Knolle P; Protzer U
    Gastroenterology; 2013 Aug; 145(2):456-65. PubMed ID: 23639914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of viral replication inhibition by entecavir on peripheral T lymphocyte subpopulations in chronic hepatitis B patients.
    You J; Sriplung H; Geater A; Chongsuvivatwong V; Zhuang L; Li YL; Lei H; Liu J; Chen HY; Tang BZ; Huang JH
    BMC Infect Dis; 2008 Sep; 8():123. PubMed ID: 18803883
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
    Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
    J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection.
    Cerino A; Mantovani S; Mele D; Oliviero B; Varchetta S; Mondelli MU
    Front Immunol; 2019; 10():2290. PubMed ID: 31608071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pre-Activation of Toll-Like Receptor 2 Enhances CD8
    Lin Y; Huang X; Wu J; Liu J; Chen M; Ma Z; Zhang E; Liu Y; Huang S; Li Q; Zhang X; Hou J; Yang D; Lu M; Xu Y
    Front Immunol; 2018; 9():1495. PubMed ID: 30008718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current status of immunomodulatory therapy in chronic hepatitis B, fifty years after discovery of the virus: Search for the "magic bullet" to kill cccDNA.
    Zhang E; Kosinska A; Lu M; Yan H; Roggendorf M
    Antiviral Res; 2015 Nov; 123():193-203. PubMed ID: 26476376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunosuppressant dexamethasone can significantly extend the expression of hepatitis B virus antigens in the HBV mouse model by hydrodynamic transfection method].
    Guo YJ; Wang W; Sun SH; Zeng DB; Zhao GY; Yu H; Guo Y; Tan WJ; Lu SC; Zhou YS
    Bing Du Xue Bao; 2010 Jan; 26(1):20-6. PubMed ID: 20329554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.